Ophthalmology clinical research - Latest News Update, Information, Photos & Videos on Ophthalmology clinical research at Lokmat Times

A group of researchers has uncovered a novel genetic mutation that could be the root cause of severe cases of paediatric glaucoma, a deadly ailment that runs in families and can deprive youngsters of their vision by the age of three.The findings were reported in 'Journal of Clinical Investigation.'The researchers discovered a mutation in the thrombospondin-1 (THBS1) gene in three ethnically and geographically varied families with a history of childhood glaucoma using modern genome-sequencing technologies. The researchers subsequently confirmed their findings in a mouse model with the genetic mutation and developed glaucoma symptoms due to a previously unknown disease mechanism.The new findings, published December 1 in the Journal of Clinical Investigation, could lead to improved screening for childhood glaucoma and more targeted treatments to prevent vision loss in children with the mutation, according to the study's authors."This is a very exciting finding for families affected by childhood glaucoma," said Janey L. Wiggs, MD, PhD, Associate Chief of Ophthalmology Clinical Research at Mass Eye and Ear and the Vice Chair for Ophthalmology Clinical Research and Paul Austin Chandler Professor of Ophthalmology at Harvard Medical School. "With this new knowledge, we can offer genetic testing to identify children in a family who may be at risk for the disease and start disease surveillance and conventional treatments earlier to preserve their vision. In the future, we would look to develop new therapies to target this genetic mutation."Leading cause of childhood blindness: Childhood or congenital glaucoma is a rare but severe disease that presents in children as early as birth and as late as 3 years of age. Despite its rarity, childhood glaucoma is responsible for 5 per cent of cases of child blindness worldwide.Glaucoma causes irreversible damage to the eye's optic nerve, often due to the buildup of pressure inside the eye (intraocular pressure, or IOP). In adults, this damage can occur over time without symptoms, which is why the disease is often referred to as a "sneak thief of sight."Uncovering the genetic underpinnings of diseaseFor decades, researchers have turned towards genetics to better understand the cause of glaucoma. When Dr Wiggs first began this line of research 30 years ago, scientists were only able to identify regions of the genome affected in glaucoma. Thanks to advances in genomic technology, researchers gained the ability to review the complete genetic makeup of individuals with and without glaucoma to determine which specific genetic mutations play a role in the disease. Research led by Dr Wiggs in 2021 used a dataset of more than 34,000 adults with glaucoma to identify 127 genes associated with the condition.To better study the genetic mutations in childhood glaucoma, Dr Wiggs and her Mass Eye and Ear team first looked at exome sequences from an American family of European-Caucasian descent who had been part of an earlier research project and found a striking and novel variant in thrombospondin-1, a well-known protein in the body involved in a number of important biological processes, such as the formation of new vessels (angiogenesis) and tissues. This mutated gene was not found in people without childhood glaucoma, nor in large population genetic databases. The amino acid altered by the mutation was evolutionarily conserved, indicating an important role in the protein function. This finding led Dr. Wiggs to connect with colleagues at Flinders University in Australia to see if they had any childhood glaucoma families with thrombospondin mutations. They surprisingly found two families with an alteration at the same amino acid: one of mixed European and Indian descent, and one Sudanese family originally from Africa."What was really striking about this finding is that these families all possessed this genetic variant, and it was not possible for them to be related because they were from such diverse backgrounds," said Dr Wiggs. "That meant there was something really important about this mutation."To further test this hypothesis, the researchers collaborated with Robert J. D'Amato, MD, PhD, the Judah Folkman Chair in Surgery in the Vascular Biology Program at Boston Children's Hospital, and a professor of Ophthalmology at Harvard Medical School. Dr. D'Amato's team developed a mouse model with the THBS1 mutation and found that the mouse also had features of glaucoma."Thrombospondin-1 is well known as a potent inhibitor of blood vessel growth, or angiogenesis," said Dr. D'Amato, who has studied angiogenesis for more than three decades. "I assumed at first that THBS1 mutations were disrupting blood vessel formation in the eye, but our animal models showed normal angiogenesis. We realized that there must be another mechanism."Specifically, D'Amato's lab showed that the mutation caused abnormal thrombospondin proteins to accumulate in the intraocular drainage structures of the eye involved with regulating IOP, which in turn, led to a buildup of pressure that damaged the optic nerve and led to the loss of retinal ganglion cells, thereby causing vision loss.This was the first time that researchers identified this kind of disease mechanism for causing childhood glaucoma."This work highlights the power of international collaborations," said study co-author Owen M. Siggs MD, DPhil, associate professor at Flinders University and the Garvan Institute of Medical Research in Australia. "There's such incredible genetic diversity across the globe, and comparing this information is becoming more and more critical for discoveries like this."Personalizing care for families with future studyThe new study has significant clinical implications, according to the researchers. While more work remains before comprehensive genetic testing can be offered, every gene that is found presents another opportunity to be able to identify causative mutations in these families through screening, according to the authors.Therapeutically, knowledge of this gene mutation can lead to earlier treatments with conventional therapies. For example, if a baby is born with this mutation, their eye care specialist can better inform the parents of the risks and develop an appropriate disease monitoring and treatment plan.Identifying this new mechanism and gene at the root of childhood glaucoma could also lead to new therapies that would target the accumulation of abnormal proteins. The researchers also aim to determine if other THBS1 mutations are involved in adult-onset disease, like primary open-angle glaucoma, or milder forms of the disease if the mutation is not as pronounced.The researchers will also continue to look for new genes associated with childhood glaucoma in the hopes of one day developing very comprehensive screening.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Ophthalmology Clinical ResearchFOLLOW

Ophthalmology clinical research, Latest News

Health :Study finds link between genetic mutation and childhood glaucoma

A group of researchers has uncovered a novel genetic mutation that could be the root cause of severe cases ... ...